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Sesquiterpene lactones of elemanolide type vernolepin 1 and
deoxyvernolepin 2 exhibit a pronounced antitumor activity against
the Walker intramuscular carcinosarcoma 256 and CCRF - CEM
human lymphoblastic leukemia cells in culture and were there-
fore, subjects of many partial and total syntheses.
The synthesis of the steroidal analogue of deoxyvernolepin
3, i. e., its key interrnediate, č-Iactone 28-hydroxy-2-oxa-5a,10a-
-cholest-6-en-3-one 4 starting from cholesterol is the subject of
this report.
Known reactions, as well as modified ones, were used in the
synthesis. A new reaction for the preparation of dimethyl acetals
with pyridinium chlorochromate and methanol was also developed.
It was found that the acetalization reaction using pyridinium
chlorochromate and methanol could be performed without affect-
ing an acid-sensitive functional groups such as the oxirane ring.
During the last 30 years more than 800 sesquiterpene lactones have
been isolated and identified from various plant species of Campasitae and
Umbelliferae, as well as from Lauraceae, Burserceae, Magnaliaceae and
Hepaticeae.1,2
It was found that the pronounced actineoplastic (anti tumor) activity
in vitro, seldom in viva, of sesquiterpene lactones is due to the IX-ethylene-y-
and/or o-lactone ring and the stereochemistry of epaxide, hydroxy and
other functional groups in their molecule."?
Bis-c-methylene sesquiterpene lactones of elemanolide type vernolepin
13,5-10 and deoxyvernolepin 211-13 (Figure 1) exhibit a pronounced anti tumor
activity against the Walker intramuscular carcinosarcoma 2568 and CCRF
- CEM human lymphoblastic leukemia cells in culturetš and were, therefore,
subjects of many partial and total syntheses.v+"?"
These facts encouraged us to synthesize the steroidal analogue of
deoxyvernolepin 3, i. e., its o-lactone key intermediate, 28-hydroxy-2-oxa-
-5IX,10IX-cholest-6-en-3-one4, starting from cholesterol*.
* Part of Ph. D. thesis of B. Š.
* The steroidal y-lactone 5 which exhibits antitumor activity against HeLa
cells has been synthesized recently."
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Retrosynthetic analysis of steroidal dilactone 3 (Scheme 1) points to
the need for the following transformations of the cholestero 1 framework:
- simultaneous introduction of exocyc1ic double bonds into ec-position
of the "(- and o-lactone rings,24
- synthesis of the y-lactone ring (ring E) by the opening of the 6(1.,7(1.-
-epoxide ring with a suitable nuc1eophile,
- synthesis of the o-lactone ring (ring A) by ozonolysis of ~2-double
bond and subsequent acification of the obtained product and
- - conversion of primary alcohol into terminal double bond (the vinyl
group) via the corresponding arylselenyl derivative.
Scheme 1
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The synthesis should envisage an intermediate with cis-5a:,lOa:-fused
A and B rings because the nucleophilic attack on the 6a:,7a:-epoxide ring
of the cholestane (5a:,lOP-) derivative yields the inappropriate trans-6p,7a:-
-diaxial product.28,29 It was expected that the regiospecific p-attack of the
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a NBA, dioxane, HCI04
b Jones, acetone
c 48010 HBr, HOAc,50=c
d NaBH4, MeOH, 0-5 =c
e Pb(OAc)4, 12,cyclohexane
f Zn, HOAc, H20
g PhCOCl, Py
h MCPBA, CH2C12
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appropriate nucleophile) on the- C-7 carbon atom of compound 8 should give
trans-"(-lactone upon acidification.
In this report, beside the o-lactone 4, the synthesis of ž-oxa-Sc.lu«-
-cholest-6,19-dien-3-one 29 via the corresponding selenide 28 is described
(Chart III).
Cholesteryl acetate 10 was treated with HOBr in dioxane solution and
bromohydrin 11 was obtained in 560/0 yield''? (Chart I). Bromohydrin 11
was oxidized with Jones reagent in acetone yielding the corresponding
bromoketone 12 (960/0). The latter compound was further transformed into
its 7a.-isomer with 480/0,HBr in acetic acid'" in 58010yield.
Reduction of bromoketone 13 with sodium borohydride in methanol'"
gave 7a-bromo-5a-cholestan-3B,6B-diol 3-monoacetate 15 (48'010),which was
further cyclized with lead tetraacetate and iodine in cyclohexane solution
to give 6~,19-epoxide 16 (920/0).30,33-36The 6~,19-epoxide ring cleavage was
effected with zinc in acetic acid and water (89010)and the obtained primary
alcohol 17 protected by esterification with benzoyl chloride in pyridine (800/0).
The epoxidation of 18 with m-chloroperoxybenzoic acid gave only the


















22;31% a PCC, CH2C12
b PCC, Me OH
c PPTS, benzene
* The yield was estimated from the IH NMR spectrum.
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-cholestan-Slš.Iš-diol 19-monobenzoate 20 under mild conditions (0.1 M KOH,
H20) in 920/0 yield.
Synthesis of enol ether 21 was accomplished via the intermediate di-
methyl acetal 33 (Chart II).
The intermediate compound 33 was prepared from alcohol 20, which
was oxidized with pyridinium chlorochromate (PCC) into the corresponding
ketone 22. The latter compound was dissolved in hot methanol together
with »black gum«37 and 3,3-dimethyl acetal 33 was obtained in 750/0 yield*,
according to 1H NMR spectrum (not isolated).
In order to establish the reaction mechanism of this facile route for the
preparation of dimethyl acetals'" from alcohols or ketones, we treated the
previously prepared 6a:,7a:-epoxy-19-benzoyloxy-5a:-cholestan-3-one 22 with
boiling methanol in the presence of pyridinium ion (originated from PyH+Cl-
or pyridinium p-toluenesulphonate (PPTS)), but without success. However,
when the same ketone was treated with methanol and PCC as catalyst,
dimethyl acetal 33 was obtained in almost the same yield as in the case
when the intermediate ketone was not isolated. Thus we presume . that the
Cr4+ ion takes part in this reaction**.
This new method for the preparation of dimethyl acetals directly from
alcohols, without isolation of intermediate ketones was presented in our
previous paper."
The mixture of 22 and 33, which could not be separated on a silica gel
column, was treated with PPTS in boiling benzene13,39 to give the expected
enol ether 21 (370/0), ketone 22 (310/0) and 7a:-hydroxy-60-p-toluenesulpho-
nyloxy-19-benzoyloxy-5a:-cholestan-3-one 23 (230/0), a product of nucleophilic
attack of tosyloxy anion on the C-6 carbon atom of 6a:,7a:-epoxide ring
(Chart II).
Inspection of Dreiding models and the 1H NMR data of 22, 23 and 34
(Figure 2) point to chair conformation of the B ring of p-toluenesulphonate











o 2.84, d, J6.7= 4 Hz
o 3.16, dd, h.6 = 4 Hz, h.8 = 2.5 Hzo 4.49 and o 4.71,AB syst., J = 12 Hz









* See experimental part. It is not clear what are the reduction products of
the Cr6+ ion in these reactions; several authors proposed that Cr4+ might be one.
For further information see. G. P i a n c ate 11 i and M. D' Aru i a, Synthesis,
(1982) 245 and reterences therein.
** Analogous results were obtained with 5a-cholest-3-one, 6~,19-epoxy-5a-
-cholestan-3-one and cholest-s-en-a-one.
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Coupling constants of J6.5 = 3.75 Hz and J6.7 = 2 Hz are in agreement
with the proposed conformation.
Methylene 2H-19 protons of keto-benzoate 34 appear as a singlet at
o 4.7240as a consequence of the diamagnetic anisotropic effect of the 3-keto
group (chemical shift of methylene R-CH20COPh protons in o 4.2041).42a-r
However, one of the H-19 protons of 6a.,7a.-epoxy-19-benzoyloxy-5Cl-cholestan-
-3-one 22 is shifted to upper field. Thus the chemical shifts of o 4.71 for
HA-19 and o 4.49 for HB-19 are assigned. Both methylene protons of tosylate
23 are shifted to the upper field and their chemical shifts are HA-19 o 4.63
and HB-9 o 4.53.
Ozonolysis of the enol ether 21 at -78 Cc in dichloromethane-methanol
solution and subsequent reduction with sodium borohydride of intermediate
hydroperoxide gave methy l-B«,7Cl-epoxy-2-hydroxy-19-benzoy loxy-ž.x-seco-Sc-
-cholestan-3-oate 24 (84%; Chart III). The 6a,7a-epoxide ring was treated
with 48% hydrobromic acid in dioxane to give bromohydrin 25 (56%) and
triol 26 (43%). Surprisingly the chair conformation was established for com-
pound 25 on the basis of the -H NMR data (Figure 3).
Chart III
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15 2.41, B2 of AB2, Jgem = J4<.5 = 11.20 Hz
H-4~
15 2.75, A of AB2, Jgem = J4~.5 = 11.20 Hz
H-6
15 2.98, d, J6.7 = 4 Hz
H-7
15 3.10, dd, h.6 = 4 Hz J7.8 = 1.8 Hz
2H-19
15 4.24 and 15 4.14, AB syst., J = 12 Hz
2H-4
15 2.81, m, W'/. = 20 Hz
H-6 and H-7
15 5.34 and 15 5.56, AB syst., J = 11.30 Hz
2H-19
15 4.35 and 15 4.23, AB syst., J = 12 Hz
2H-2, H-6 and H-7
15 3.73, m, W'/, = 15 Hz
2H-4 and H-5
15 2.32, m, W'/, = 25 Hz
2H-19




15 4.40, m, W'/, = 5 Hz
H-7
15 4.06, m, W'/, = 7.5 Hz
2H-19
15 4.82 and 15 4.46, AB syst., J = 12 Hz
Figure 3
Shold the B ring of 25 exist in one of the two possible boat confor-
mations (bot unfavourable because of strong 1,2-diequatorial inter action of
the 6~-bromine atom and 7tx.-hydroxy group), the H-7 proton will appear
as dd with J ~ 10-12 Hz, or as a singlet. However, W'/. = 7.5 Hz was found
for the H-7 proton, which together with a great downfield shift of both
H-19 protons* (Table I) confirms the proposed conformation of the B ring.
Finally, the o-lactone 4 was prepared from bromohydrin 25 by reductive
introduction of the ~6-double bond with zinc in acetic acid and water (72'0/0),
TABLE I
HA HB
24 2H-19 15 4.24 15 4.14 AYAB= 8.0 Hz
27 2H-19 15 4.35 15 4.23 AYAB= 9.6 Hz
26 2H-19 15 4.68 15 4.47 AYAB= 16.8 Hz
25 2H-19 15 4.82 15 4.46 AYAB= 28.8 Hz
* Characteristic influence ofaxial 6~-substituents.42e.42t
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alkaline hydrolysis and subsequent acidification with concentrated hydro-
chloric acid with out isolation of the intermediate compound (84%; Chart III).
An analogous reaction scheme was applied to the synthesis of o-lactone
31 from triol 26.
Introduction of the vinyl group to the 10cx.-position of the lactone 4 was
performed with o-nitrophenyl selenocyanate and tri-n-butylphosphine in
THF26,27and the obtained yellow 28-o-nitrophenylseleno-2-oxa-5cx.,10cx.-cholest-
-6-en-3-one 28 (900/0) was treated with 300/0 hydrogen peroxide to give 2-oxa-
-5cx.,10cx.-cholest-6,19-dien-3-one 29 in 910f0 yield.
Inspection of Dreiding models suggested that the synthesized o-lactones







conformations* shown in Figure 4. Analysis of the 1H NMR data of the
obtained lactones (Table II) indicates that conformations I, III and V of
4, 29 and 31, respectively, can be found in CDCh or acetone-d, solutions.
Distorted chair conformation of the o-lactone ring is proposed on the basis
of the great downfield shift of H-1~ protons (o 4.37, o 4.39 and o 4.89) caused
by the diamagnetic anisotropic effect of the carbonyl group of the lactone
ring on H-1~ proton.
The great downfield shift of the H-1~ proton of o-lactone 31 (o 4.89)
is indicative of an additional effect of the axial 6~-hydroxy group.
The half-chair conformation of the B ring of 4, 28 and 29 is proposed
on the basis of J6,7 = 10 Hz, h5 = 1.2 Hz and hs = 1 Hz. In the case of the
boat conformation of the B ring (structures II and IV; Figure 4) the coupling
constant J6,5 ~ 8-10 Hz should be found.
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EXPERIMENTAL
Melting points were taken on the Boetius PHMK apparatus and were not
corrected. IR spectra were recorded (KBr pellets or film) on a Perkin-Elmer
spectrophotometer, model 457. lH NMR spectra were recorded on a Varian FT-80A
spectrometer in CDC13and acetone-ds using tetramethylsilane as internal standard.
Chemical shifts were expressed in terms of ppm (~) values and coupling constants
(J) in Hz. 13CNMR spectra were record ed on a Varian FT-80A spectrometer at
20 MHz in CDC13 and acetone-ds,
5a-BTomo-5a-eholestan-3/3,6/3-diol 3-monoaeetate 11
Bromohydrin 11 was synthesized from cholesterol according to the known
procedure of Kalvoda et aL-30 (38 g, 56010 m. p. 172-174°C).
5a-BTomo-3/3-aeetoxy-5a-eholestan-6-one 12
Bromohydrin 11 was dissolved in acetone and oxidized with Jones reagent.
After the usual work-up procedure, bromoketone 12 (36.5 g, 96010; m. p. 158-160 =c
(EtOH)) was obtained.
7a- Broma-S /3-aeetoxy-5a-eho leetan-6-one 13
Isomerization of 5a-bromo-6-ketone 12 into 7a-bromo isomer 13·was performed
with 48010 hydrobromic acid in acetic acid aecording to Heilbron et. aL-3l (20.8 g, 58010;
m. p. 142-145 ° (EtOH)).
7a-BTomo-5-a-eholestan-3/3,6/3-diol 3-monoaeetate 15
7a-Bromoketone 13 was reduced with sodium borohydride in methanol solution
at 0-5 -c, After work-up and separation on a silica gel column bromohydrin 15
was obtained (14 g, 48010; m. p. 179-1800C (EtOH)) together with its epimer,
7a-bromo-5a-cholestan-3~,6a-diol 3-monoacetate 14 (15 g, 52010; m. p. 162-163 -c
(EtOH)).
7a-BTOmo-6/3,19-epoxy-5a-eholestan-3/3-o1 3-aeetate 16
A suspension of lead tetraacetate (76 g; 0.171 mole) and calcium carbonate
(34 g) in cyclohexane (1666 ml) were stirred at reflux for 20 min. Upon addition
of bromohydrin 15 (15 g; 0.029 mole) and iodine (16.5 g; 0.065 mole) the reaction
mixture was irradiated with a Wolfram lamp (500 W) for 40 minutes. The cooled
reaction mixture was filtered through celite, the filtrate was diluted wtth ether
and washed with 10010 sodium tiosulphate and water and dried over anhydrous
magnesium sulphate. Magnesium sulphate was filtered off, the filtrate evaporated
in vaeuo and the residue crystallized from methanol and ether to give 7a-bromo-
-6/3,19-epoxy-5a.-eholestan-3{J-ol 3-acetate 16, 13.7 g (92010), m. p. 126-128°C (MeOHI
jether), lit.33 m. p. 129-130oC; [a]D20= -62.30° (c = 1.00, ehl.); IR (KBr): y 1740,
1245, 1235, 1197, 1038, 1022, 970, 962, 936, 922, 905 cm! ; lH NMR (CDC13): s 0.'75
(3H, s, H-18), 0.88 (6H, d, J = 6 Hz, H-26 and H-27), 0.93 (3H, d, J = 6 Hz, H-21),
2.05 (3H, s, -OCOCH3), 2.56 (IH, dd, J8.7 = 4 Hz, J8.9 = 12 Hz, H-8), 3.69 and 3.87
(2H, AB system, J = 8.8 Hz, H-19), 4.09 (2H, m, Wlf, = 17.5 Hz, H-6 and H-7),
4.73 (IH, m, W,/, = 25 Hz, H-3).
5a-Cholest-6-en-3/3,19-diol 3-monoaeetate 17
Powdered zinc (91 g) was added to a solution of 6~,19-epoxide 16 (13.6 g; 0.026
mole) in glacial acetic acid (456 ml) and water (20 ml) at 45-500C while the
reaction mixture was vigorously stirred. After 40 min the reaetion mixture was
colled to room temperature, inorganic material filtered off and the filtrate evapo-
rated in vaeuo. The obtained oily residue was dissolved in the mixture of ether
and chloroform (5 : 1) and washed with asaturated solution of sodium bicarbonate
and water. The dried solution was evaporated in vaeuo and the residue crystallized
from a mixture of methanol and chloroform to give 5a.-cholest-6-en-3{J,19-diol 3-mo-
noaeetate 17, 10.4 g (89010), m. p. 147-149°C (MeOH/CHC13), lit.33 m. p. 102-103°C:
[a]D15= -94.94° (c = 1.12, chl) ; IR (KBr): y 3520, 3040, 1650, 1265, 1055, 1045, 1029,
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995, 985 cm-I IH NMR (CDCI3): <5 0.73 (3H, s, H-18), 0.87 (6H, d, J = 6 Hz, H-26 and
H-27), 0.90 (3H, d, J = 6 Hz, H-21), 2.03 (3H, s, -OCOCH3), 3.85 (2H, s, H-19), 4.75
(IH, m, Wl/, = 30 Hz, H-3), 5.24 and 5.51 (2H, AB system, J = 10 Hz, H-16 and H-7).
Anal. C29H4S03(444.72)ealc'd: C 78.33; H 10.88010
found: C 78.01; H 10.74010.
5a-Cholest-6-en-3/3,19-diol 3-aeetate 19-benzoate 18
Monoaeetate 17 (10.4 g; 0.023 mole), dissolved in pyridine (48 ml), was treated
with benzoyl ehloride (10.4 ml; 0.09 mole) at room temperature. After the usual
work-up the obtained oily residue erystal1ized from methanol to give 5a-cholest-6-
-en-3jJ,19-diol 3-acetate 19-benzoate 18, 10.1 g (80010),m. p. 126-128°C (MeOH);
[ah17 = -58.15° (c = 0.92, ehl.); IR (KBr): jJ 3030, 1745, 1730, 1650, 1620, 1600,
1275, 1240, 1180, 1115, 1073, 1055, 1030, 715 cm-I; IH NMR (CDCI3): <5 0.65 (3H, s,
H-18), 0.86 (6H, d, J = 6 Hz, H-26 and H-27), 0.93 (3H, d, J = 6 Hz, H-21), 2.05
(3H, s, -OCOCH3), 4.46 and 4.68 (2H, AB system, J = 12 Hz, H-19), 4.80 (IH, m,
W'1z = 30 Hz, H-3), 5.28 and 5.56 (2H, AB system, J = 10 Hz, H-6 and H-7), 7.28-
-8.05 (5H, arom.).
Anal. C36H5204 (548.81) calc'd.: C 78.79; H 9.55010
found: C 79.04; H 9.57010.
6a,7a-Epoxy-5a-cholestan-3/3,19-diol 3-acetate 19-benzoate 19
10.1 g (0.018 mole) of 18, dissolved in diehloromethane (163 ml), was treated
with m-ehloroperoxybenzoic acid (4.2 g; 0.024 mole). The reaction mixture was
left overnight, washed with asaturated solution of sodium bicarbonate and water.
The dried organic solution was evaporated in vacuo and the obtained residue
crystal1ized from methanol to give 6a,7a-epoxy-5a-cholestan-3/3,19-diol 3-aeetate
19-benzoate 19, 10 g (96010),m. p. 110-112°C (MeOH) ; [a]o16 = -18.24° (e = 1.17,
ehl.); IR (KBr): jJ 3050, 1730, 1595, 1582, 1262, 1245, 1180, 1105, 1074, 1050, 1025, 725
cm-I; IH NMR (CDCI3): <5 0.64 (3H, s, H-18), 0.87 (6H, d, J = 6 Hz, H-26 and H-27),
0.91 (3H, d, J = 6 Hz, H-21), 2.05 (3H, s, -OCOCH3), 2.83 (IH, d, h7 = 4 Hz, H-S),
3.11 (IH, dd, J7,6= 4 Hz, h,s = 2.5 Hz, H-7), 4.37 and 4.64 (2H, AB system, J = 12
Hz, H-19), 4.76 (IH, m, Wl/, = 30 Hz, H-3), 7.28-8.10 (5H, arom.).
AnaL C36H52H5 (564.81) calc'd.: C 76.55; H 9.28010
found: C 76.90; H 9.33010.
6a,7a-Epoxy-5a-cholestan-3/3,19-diol 19-monobenzoate 20
A solution of potassium hydroxide in water (1 g KOH in 2.7 ml H20) was
added to the stirred solution of 19 (10 g; 0.018 mole) in ethanol (259 ml) at room
temperature. After 90 min, the reaetion mixture was poured into cold water and
aeidified with diluted hydroehlorie acid. The preci pitate was filtered off, washed
well with water and erystal1ized from methanol to give 6a,7a-epoxy-5a-eholestan-
-3/3,19-diol 19-monobenzoate 20, 8.5 g (92010),m. p. 107-109°C (MeOH); [a]ols =
= --':13.09° (e = 1.12, chl.) ; IR (KBr): jJ 3350, 1730, 1610, 1595, 1180, 1115, 1075, 1032,
719 cm-I; IH NMR (CDC13): <5 0.63 (3H, s, H-18), 0.85 (6H, d, J = 6 Hz, H-26 and
H-27), 0.88 (3H, d, J = 6 Hz, H-21), 2.83 (IH, d, h7 = 4 Hz, H-6), 3.13 (IH, dd, J7,6=
= 4 Hz, h,s = 2.5 Hz, H-7), 3.70 (IH, m, Wl/, = 18 Hz, H-3), 4.36 and 4.60 (2H, AB
system, J = 12 Hz, H-19), 7.28-8.08 (5H, arom.).
AnaL CS4H5004 (522.81) eale'd.: C 78.12; H 9.64010
found: C 77.84; H 9.45010.
3-Methoxy-6a, 7a-epoxy-5a-cholest-2-en-19-o1 19-benzoate 21
To a solution of aleohol 20 (8.5 g ; 0.016 mole) in dichloromethane (223 ml)
pyridinium ehloroehromate (12.6 g; 0.058 mole) was added in small portions. The
reaetion was meehanieally stirred for four hours at room temperature. After the
oxidation was finished (TLC), the supernatant was poured off and the precipitate
washed with dry ether (3 X 100 ml). The eombined solutions were left at room
temperature for 45 min, the precipitate was filtered off and the filtrate evaporated
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in vacuo. The obtained brown-reddish oi! was dissolved in methanol (100 ml) and
solution refluxed for 20 minutes. The resulting green-coloured the solution was
evaporated in vaeuo and the oily residue eluted with benzene through ashort
siliea gel eolumn. The obtained eolourless oi! was dissolved in dry benzene (223
ml), pyridinium p-toluenesulphonate was added (0.95 g; 0.004 mole) and the reaetion
mixture refluxed for 30 minutes. The eooled reaetion mixture was twiee washed
with water, dried over anhydrous magnesium sulphate and evaporated in vaeuo.
After separation on a siliea gel eolumn enol ether 21, ketone 22 and p-toluene-
sulphonate 23 were isolated. 3-methoxy-6a,7a-epoxy-5a-choLest-2-en-19-oL 19-ben-
zoate 21, 3.2 g (37010),oil; [aJnI8:= +24.440 (e:= 0.71, chl.): IR (KBr): v 3055, 1718,
1665, 1600, 1582, 1270, 1213, 1180, 1110, 1070, 1028, 712 cm-I; IH NMR (CDCI3): il 0.61
(3H, s, H-18), 0.86 (6H, d, J:= 6 Hz, H-26 and H-27), 0.90 (3H, s, J:= 6 Hz, H-21),
2.95 (2H, d, J6.7:= 4 Hz, H-6), 3.13 (IH, dd, J7.6:= 4 Hz, h.8:= 2.5 Hz, H-7), 3.50 (3H,
s, -OCH3), 4.30 and 4.40 (2H, AB system, J:= 12 Hz, H-19), 4.58 (IH, d, J2.1.:= 3.5
Hz, H-2), 7.28-8.08 (5H, arom.).
AnaL. C35H5004 (534.81) ea1e'd.: C 78.61; H 9.42010
found: C 78.01; H 9.69010.
6a,7a-epoxy-19-benzoyLoxy-5a-choLestan-3-one 22, 2.7 g (310/0), oil ; [aJn23:=
= +14.710 (c = 0.64, chl.) ; IR (film): v 3055, 1717, 1600, 1585, 1270, 1110, 1100, 1072,
1028, 715 cm-I; IH NMR (CDCh): il 0.69 (3H, s, H-18), 0.86 (6H, d, J = 6 Hz, H-26
and H-27), 0.88 (3H, d, J:= 6 Hz, H-21), 2.84 (IH, d, J6.7 = 4 Hz, H-6), 3.16 (IH, dd,
J7,6 = 4 Hz, J7.8 = 2.5 Hz, H-7), 4.49 and 4.71 (2H, AB system, J = 12 Hz, H-19),
7.27-8.08 (5H, arom.).
7a-hydroxy-6j3-p-toLuenesulphonyloxy-19-benzoyloxy-5a-eholestan-3-one 23, 2.5
g (23010),oil; [aJn20.5:=+ 11.48° (e:= 0.82, eh!.); IR (film): v 3500, 3060, 1715, 1600,
1585, 1271, 1191, 1179, 1112, 1099, 1072, 1023, 938, 715, 677 cm-I; IH NMR (CDCla):
<5 0.69 (3H, s, H-18), 0.86 (6H, d, J = 6 Hz, H-26 and H-27), 0.89 (3H, d, J = 6 Hz,
H-21), 2.45 (3H, s, CH3/TsO-), 3.91 (IH, m, W,/. = 7.5 Hz, H-7), 4.36 (IH, dd, J6.5 =
:= 3.75 Hz, Ja.7 = 2 Hz, H-6), 4.53 and 4.63 (2H, AB system, J = 13 Hz, H-19),
7.33-8.04 (9H, arom.).
Methyl-6a, 7a-epoxy-2-hydroxy-l 9-benzoyloxy-2 ,3-seco-5a-
-cholestan-3-oate 24
Through a solution of enol ether 21 (0.05 g; 9 x 10-5 mole) in dichloromethane
(4.1 ml) and methanol (0.1 ml) ozone (- 5010)was bubbled for 5 min at -78°C.
After the reaetion was over (TLC), ozone was replaeed by an argon atmosphere,
the reaetion mixture warmed to -20 =c and methanol (1 ml) added, followed by
sodium borohydride (0.014 g; 3.70 X 10-4 mole). After the reduetion was eompleted,
the reaetion mixture was aeidified with glacial aeetie acid (-20 -c ~ O °C). The
organic layer was washed with water, dried over anhydrous magnesium sulphate
and evaporated in vacuo to give, methyl-6a,7a-epoxy-2-hydroxy-19-benzoYloxy-
-2,3-seco-5a-cholestan-3-oate 24, 0.044 g (84010),oil ; [alol9 = -27.66° (e = 0.53, chl.);
IR (KBr): v 3440, 3055, 1735, 1718, 1660, 1582, 1270, 1177, 1110, 1070, 1028, 712 cm-I;
IH NMR (CDCI3): <5 0.66 (3H, s, H-18), 0.88 (6H, d, J = 6 Hz, H-26 and H-27), 0.91
(3H, d, J = 6 Hz, H-21), 2.41 (2H, B2 of AB2 system, J.,m = J4 e ,5 := 11.2 Hz, H-4a. and
H-5), 2.75 (IH, A of AB2 system, J.,m:= J4~.5 := 11.2 Hz, H-4~), 2.98 (IH, d, J6:i = 4
Hz, H-6), 3.10 (IH, dd, Ji.e= 4 Hz, J7.8:= 1.8 Hz, H-7), 3.69 (2H, t, J:= 6 Hz, H-2),




A solution of epoxide 24 (1.60 g; 2.8 X 10-3 mole) in dioxane (57 ml) and water
(4.73 ml) was treated with 48010hydrobromic aeid (4.70 ml) and stirred for 45 min
at room temperature. The reaetion mixture was diluted with water (20 ml),
extraeted with ether (3 X 40 ml) and the etheral solution washed with asaturated
sodium biearbonate solution and water. The dried solution was evaporated in
vacuo and after separation on a siliea gel eolumn bromohydrin 25 and triol 26 were
obtained, methyl-6j3-bromo-2,7a-dihydroxy-19-benzoyloxy-2,3-seco-5a-cholestan-3-
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-oate 25, 1.02 g (560/0), m. p. 149-151 =c (chl./hexane); [alo20 = +11.07° (c = 0.85,
chl.); IR (KBr): ')J 3435, 3055, 1722, 1710, 1600, 1585, 1275, 1176, 1027, 712 cm-I; -n
NMR (CDCI3): i5 0.75 (3H, s, H-18), 0.89 (6H, d, J = 6 Hz, H-26 and H-27), 0.93 (3H,
d, J = 6 Hz, H-21), 2.64 (3H, s, H-4 and H-5), 3.71 (3H, s, -COOCH3), 3.75 (2H, m,
W,/. = 15 Hz, H-2), 4.06 (IH, m, W,/. = 7.5 Hz, H-7), 4.40 (IH, m, W,/, = 5 Hz, H-6),
4.46 and 4.82 (2H, AB system, J = 12 Hz, H-19), 7.29-8.19 (5H, arom.).
AnaI. C35H53Br06 (649.70) calc'd.: C 64.70; H 8.22010
found: C 64.80; H 7.88010
methyl-2,6j3,7a-trihydroxY-19-benzyloxy-2,3-seco-5a-cholestan-3-oate 26, 0.71 g
(430/0), m.p. 177.5-179.5°C (chl./hexane); [aJo19= 0° (c = 0.67, chl.) ; IR (KBr): ')J
3450, 3330, 3245, 3055, 1732, 1690, 1600, 1582, 1277, 1240, n80, 1168, 1029, 712 cm-I;
IH NMR (CDCI3): s 0.68 (3H, s, H-18), 0.87 (6H, d, J = 12 Hz, H-26 and H-27), 2.32
(3H, m, Wl1z = 25 Hz, H-4 and H-5), 3.67 (3H, s, -COOCH3), 3.73 (4H, m, W,/, = 15·
Hz, H-2, H-6 and H-7), 4.47 and 4.68 (2H, AB system, J = 12 Hz, H-19), 7.28-8.11
(5H, arom.).
Ana!. CS5H5407 (586.81) ealc'd.: C 71.64; H 9.28010
found: C 71.87; H 9.10010.
Methyl-2-hydroxy-2,3-seco-5a-cholest-6-en-3-oate 27
Powdered zinc (5.41 g) was added to a solution of bromohydrin 25 (1.02 g;
1.6 X 10-3 mole) in glacial aeetic acid (27 ml) and water (1.2 ml) at 45-50 -c
while the reaction mixture was vigorously stirred. After 40 min the reaction
mixture was cooled to room temperature, the inorganic material filtered off and
the filtrate evaporated in vaeuo. The obtained oily residue was dissolved in the
mixture of ether and ehloroform (5: 1) and washed with saturated sodium
bicarbonate solution and water. The dried solution was evaporated in vacuo
and the residue eluted through ashort silica gel column to give methyl-2-hydroxy-
-2,3-seeo-5a-cholest-6-en-3-oate 27, 0.62 g (72010), oil; [alo23= -68.05° (c = 1.15,
ehl.); IR (film): ')J 3500, 3055, 3015, 1735, 1720, 1640, 1600, 1585, 1272, 1178, 1112,
1022, 978, 712 cm'"; IH NMR (CDC1a): i5 0.66 (3H, s, H-18), 0.86 (6H, d, J = 6
Hz, H-26 and H-27), 0.89 (3H, d, J = 6 Hz, H-21), 2.81 (2H, m, Wl/, = 20 Hz, H-4),
3.66 (3H, s, -COOCH3), 3.71 (2H, m, w», = 15 Hz, H-2), 4.23 and 4.35 (2H, AB
system, J = 12 Hz, H-19), 5.34 and 5.56 (2H, AB system, J = 11.3 Hz, H-6 and
H-7), 7.28-8.08 (5H, arom.).
28-Hydroxy-2-oxa-5a,1 Oa-cholest-6-en-3-one 4
A solution of potassium hydroxide (0.2 g KOH in 2 ml H20) was added to
a suspension of 27 (0.54 g; 9.8 X 10-4 mole) in methanol (3 ml) and the reaction
mixture was left on a steam bath for 15 min and acidified with eoncentrated
hydrochloric acid. The obtained suspension was extraeted with ether and chloro-
form (5: 1), the separated organic solution washed with saturated sodium bicar-
bonate solution and water, dried over anhydrous magnesium sulphate and
evaporated in vacuo. Crystallization from ehloroform and hexane gave 28-hydroxy-
-2-oxa-5a,10a-cholest-6-en-3-one 4, 0.34 g (84010),m. p. 102-103.5 =c (chl./hexane);
[alo1S= -78.16° (c = 0.77, ehl.); IR (KBr): ')J 3440, 3010, 1735, 1650, 1060 cm-I;
1H NMR (CDC13): i5 0.71 (3H, s, H-18), 0.86 (6H, d, J = 6 Hz, H-26 and H-27),
0.92 (3H, d, J = 6 Hz, H-21), 1.73 (2H, t, J = 7.5 Hz, H-19), 2.29 (IH, m, W,/, = 25
Hz, H-5), 2.80 (2H, m, Wl/, = 31.25 Hz, H-4), 3.80 (2H, d, J == 7.5 Hz, H-28), 3.83
and 4.37 (2H, AB system, J == 12 Hz, H-1), 5.43 (IH, ddd, Je.t == 10 Hz, h.5 == 1.2
Hz, J6.8 = 1 Hz, H-6), 5.73 (IH, d, J7.6== 10 Hz, H-7); 13C NMR (CDC13): s 172.9
(C-3), 132.0 and 129.0 (C-6 and C-7), 71.5 (C-1), 58.4 (C-28), 36.1 (C-22), 35.7
(C-20), 28.1 (C-16), 28.0 (C-24), 23.8 (C-23), 22.5 and 22.6 (C-26 and C-27), 18.7
(C-21), 11.9 (C-18).
Anal. C27H440S (416.64) ealc'd: C 77.84; H 10.64010
found: C 78.10; H 10.54010.
Aeetylation of 4 with aeetie anhydride in pyridine gave 28-acetoxy-2-
-oxa-5a,10a-eholest-6-en-3-one 30, oil ; IR (film): ')J 3010, 1755, 1737, 1660, 1232,
1065 cm": IH NMR (CDC13): i5 0.73 (3H, s, H-18), 0.89 (6H, d, J == 6 Hz, H-26
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and H-27), 0.93 (3H, d, J = 6 Hz, H-21), 1.83 (2H, t, J = 7.5 Hz, H-19), 2.07 (3H,
s, -OCOCHs), 2.32 (IH, m, W,/, = 25 Hz, H-5), 2.78 (2H, m, W,/, = 31.25 Hz, H-4),
3.84 and 4.39 (2H, AB system, J = 12 Hz, H-1), 4.14 (2H, t, J = 7.5 Hz, H-28),
5.43 (IH, ddd, J6.7 = 10 Hz, J6.5 = 1.2 Hz, J6.8 = 1 Hz, H-6), 5.73 (IH, d, h.6 = 10
Hz, H-7).
6(3,7a,2 8-Trihydroxy-2-oxa-5a,1 Oa-cholestan-3-one 31
<5-Lactone 31 was obtained in the same manner from triol 26 as 4 from 27.
6/J,7a,28-trihydroxY-2-oxa-5a,10a-choLestan-3-one 31, 0.37 s. (740/0), m. p. 193-195°C
(EtOAc); [alo19.5 = +17.35° (c = 0.70, chl.); IR (KBr): y 3410, 1705, 1225, 1067, 1050,
1021, 986 cm-i; iH NMR (acetone-đ-): <50.71 (3H, s, H-18), 0.86 (6H, d, J = 6 Hz,
2.81 (2H, m, W,/, = 26.85 Hz, H-4), 3.64 (2H, d, J = 7.5 Hz, H-28), 3.74 (2H, d,
W,/, = 12.5 Hz, H-6 and H-7), 3.86 (IH, dd, .Tg•m = n.25 Hz, J = 2.5 Hz, H-1a),
4.89 (IH, d, s.: = 11.25 Hz, H-1~); i3C NMR (aceton-đs) : <5171.2 (C-3), 76.2 and
'75.7 (C-6 and C-7), 71.4 (C-1), 57.2 (C-28), 36.7 (C-22), 35.9 (C-20), 24.1 (C-23),
23.1 and 22.8 (C-26 and C-27), 19.1 (C-21), 12.2 (C-18).
AnaL C27H4605 (450.66) calc'd: C 71.96; H 10.29%
found: C 72.46; H 10.53%.
Acetylation of 31 with acetic acid anhydride in pyridine gave 6/J,7a,28-
-triacetoxy-2-oxa-5a,10a-choLestan-3-one 32, oil ; IR (KBr): y 1755, 1735, 1265,
1234, 1210, 1060, 1032, 970 cm-i; iH NMR (CDCI3): <50.69 (3H, s, H-18), 0.86 (6H,
-d, J = 6 Hz, H-26 and H-27), 0.91 (3H, d, J = 6 Hz, H-21), 2.06 (3H, m, -OCOCH~),
2.08 (3H, s, -OCOCH3), 2.11 (3H, s, -OCOCH3), 2.31 (IH, m, W,/, = Hz, H-5),
2.86 (2H, m, W,/, = 41.25 Hz, H-4), 4.01 (IH, dd, J.,," = 11.25 Hz, J = 2.5 Hz, H-1a),
4.18 (2H, t, J = 7.5 Hz, H-28), 4.76 (IH, d, s.: = 11.25 Hz, H-1~), 4.86 (IH, m,
W,/, = 5.5 Hz, H-7), 5.05 (IH, t, J = 3.25 Hz, H-6).
28-o-nitrophenylseleno-2-oxa-5a,1 Oa-cholest-6-en-3-one 28
<5-Lactone 4 (0.15 g, 3.6 X 10-4 mole) dissolved in dry tetrahydrofurane (2 ml)
was treated with o-nitrophenyl selenocyanate (0.13 g; 5.7 x 10-4 moler" and tri-
-n-butylphosphine. When the reaction was over (determined by disappearance of
the deep-red colour) the solution was evaporated in vacuo and the obtained
oil wafi eluted through ashort silica gel column. Crystallization from hexane
afforded 28-o-nitrophenyLseLeno-2-oxa-5a,10a-choLest-6-en-3-one 28, 0.18 g (90%),
m. p. 105-106°C (hexane) ; [alo'o = -15.55° (c = 0.86, acetone) ; IR KBr): y 3010,
1750, 1720, 1690, 1582, 1560, 1503, 1335, 1297, 847, 782, 730 cm-i; H NMR (CDCls):
<50.74 (3H, s, H-18), 0.86 (6H, d, J = 6 Hz H-26 and H-27), 0.93 (3H, d, J = 6 Hz,
H-21), 2.33 (IH, m, W,/, = 26.25 Hz, H-5), 2.83 (4H, m, W,/, = 28.75 Hz, H-4 and
H-28), 3.84 and 4.41 (2H, AB system, J = 12 Hz, H-1), 5.48 (IH, ddd, J6.7 = 10 Hz,
·J6.5= 1.2 Hz, h,a = 1 Hz, H-6), 5.82 (IH, d, h.6 = 10 Hz, H-7).
AnaL C33H4704NSe(600.70) calc'd.: C 65.98; H 7.89; N 2.33°,'0
found: C 66.62; H 7.73; N 3.61%.
2-0xa-Sa,1 Oa-cholest-6,1 9-dien-3-one 29
A solution of 28 (0.15 g; 2.5 X 10-4 mole) in tetrahydrofurane (2 ml) was
cooled to O =c and treated with 30% hydrogen peroxide (1 ml). The reaction
mixture was left overnight at room temperature, extracted with ethyl acetate
and washed with saturated sodium bicarbonate solution and water. The dried
.solution was evaporated in vacuo and the resulting oil crystallized from methanol
to give 2-oxa-5a,10a-choLest-6,19-dien-3-one 29, 0.091 g (91%), m. p. 84-850C
(MeOH); [aJo25 = -87.70° (c = 0.61, chl.): IR (KBr): y 3070, 3010, 1750, 1725, 1712,
1690, 1627, 1280, 1205, 1181, 1147, 1052, 1031, 1007, 920, 729, 700 cm-i; iH NMR (CDCI~):
<50.71 (3H, s, H-18), 0.88 (6H, d, J = 6 Hz, H-26 and H-27), 0.91 (3H, d, J = 6 Hz,
H-21), 2.56 (3H, m, W,/, = 50 Hz, H-4 and H-5), 4.39 (2H, s, H-1), 5.14 (IH,
dd, J28.,19=10 Hz, J28.,28A=2.5 Hz, H-28.), 5.43 (IH, dd, J28A,19=15 Hz, J28,,280=2.5
Hz, H-28), 5.49 (IH, ddd, J6.7 = 10 Hz, Je» = 1.2 Hz ha = 1 Hz, H-6), 5.66 (IH,
-d, J6.7 = 10 Hz, H-7), 5.68 (IH, dd, J19,28A = 15 Hz, J19,28. = 10 Hz, H-19).
AnaL C27H4202 (398.63) calc'd: C 18.35; H 10.62%
found: C 81.53; H 10.23%.
rpifv..1
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IZVOD
Steroidni analozi đeoksivernoleplna, Sinteza l)-laktonskog ključnog intermedijera
Bogdan ŠoLaja i MHutin Stefanović
Seskviterpenski laktoni elemanolidnog tipa vernolepin 1 i deoksivernolepin
2 pokazuju izraženu antitumorsku aktivnost protiv Walker-ovog intramusku-
larnog karcinosarkoma 256 i CCRF - CEM humanih limfoblastičnih ćelija leuke-
mije u kulturi i stoga su bili predmet mnogih parcijalnih i totalnih sinteza.
Zbog značajnog aktineoplastičnog (antitumorskog) dejstva seksviterpenskih
laktona sa a-meti1enskom funkcijom na y- i č-Iaktonskorn prstenu sintetizovan
je polazeći od holesterola, steroidni analog deoksivernolepina 3, odnosno ključni
intermedijer u njegovoj sintezi 28-hidroksi-2-oksa-5a,10a-holest-6-en-3-on(4).
U sintezi su primenjene poznate reakcije, neke su modifikovane, a upotre-
bljena je i nova reakcija za dobivanje dimetil-acetala pomoću metanola i pirt-
dinijum-hlorohromata. Ovim reagensom mogu se reakcije acetalizacije vršiti u
prisustvu osetljivih funkcionalnih grupa kao što je epoksidna grupa.
